Silexion Therapeutics receives Nasdaq panel approval for continued listing

Related
BTCS ups capital raise target for Ethereum purchases to $225...
11 minutes ago
0
BP to sell 300 Dutch gasoline stations, part of $20B divestm...
15 minutes ago
0
Starlink lands the final approval needed to launch a commerc...
16 minutes ago
0
The CEO of David’s Bridal buys clothes from Goodwill and eBa...
16 minutes ago
0
The problem with Trump’s plan to tax copper is that the U.S....
18 minutes ago
0
J&J wins appeals court ruling against Teva and Viatris in pa...
19 minutes ago
0
Arm sees 14-fold growth in data center customers since 2021 ...
21 minutes ago
0
B. Riley amends credit deal with Oaktree
24 minutes ago
0
Volkswagen Q2 sales impacted by slump in North America deliv...
32 minutes ago
0
Mortgage applications soar as rates get lower
32 minutes ago
0
DOJ questions former UnitedHealth staff on Medicare billing ...
36 minutes ago
0
‘Shut up, Dan’ — Elon Musk snaps at Tesla bull Dan Ives afte...
37 minutes ago
0
Venture Global secures new 20-year LNG contract with SEFE fo...
42 minutes ago
0
Virgin Atlantic will use Musk’s Starlink for fleet Wi-Fi
46 minutes ago
0
China Automotive Systems starts mass production of new L2+ a...
48 minutes ago
0
Merck confirms $10B buyout of Verona Pharma
51 minutes ago
0
Sam Altman saw Musk’s fallout with Trump coming: ‘Elon busts...
58 minutes ago
0
Domino's Pizza continues to grow its presence in the Middle ...
58 minutes ago
0
Special Opportunities Fund declares $0.1098 dividend
1 hour ago
0
Trending
Popular
© FBT Company 2025. All rights are reserved